Research location
Saint Petersburg
Russia
Research activity in Saint Petersburg
RussiaCureCurrent currently publishes aggregate city-level research activity for this location: 1,647 trials and 4,090 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Saint Petersburg
1,647 linked trials · page 1 of 33A Prospective, Single-center, Non-randomized, Interventional Study on the Effectiveness and Safety of Combined Immunotargeted Therapy in Patients With Metastatic Non-small Cell Cancer With a RET Gene TranslocationNCT07809256 · 2026-09-01 · 1 site observation
RECRUITING
Efferon LPS Hemoadsorption in Cardiac Surgery PatientsNCT07532174 · 2026-04-22 · 2 site observations
RECRUITING
Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world PracticeNCT06905301 · 2026-01-23 · 3 site observations
RECRUITING
Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in RussiaNCT06930859 · 2025-12-03 · 3 site observations
RECRUITING
A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1NCT07292168 · 2025-12-02 · 1 site observation
RECRUITING
Efficacy and Safety of DMB-I (INN: Latrepirdine) in Patients With Alzheimer Type DementiaNCT07251023 · 2025-11-20 · 5 site observations
RECRUITING
Evaluation of the Efficacy and Safety of Using Platelet-rich Fibrin (PRF)-Based Lipobolus for the Immediate Reconstruction of Defects After Breast-conserving Resection for Breast Cancer (Minimally Invasive Primary Immediate Grafting)NCT07658170 · 2025-11-13 · 1 site observation
RECRUITING
Aggressive Disease Treatment Patterns and CtDNA HRR evaluatiON in High-volume metastatiC hORmone-sensitive Prostate Cancer in Russian FeDerationNCT07052578 · 2025-06-30 · 2 site observations
RECRUITING
Carbon Suspension vs. Metallic Marker for Axillary Lymph Node Marking in Breast Cancer After Neoadjuvant TherapyNCT07106112 · 2025-05-15 · 1 site observation
RECRUITING
BCD-236 in Combination With Chemotherapy in Patients With Relapsed and/or Metastatic Triple Negative Breast CancerNCT07108309 · 2024-07-15 · 10 site observations
RECRUITING
Clinical& Demographic Profiles of patIents With unControllEd Asthma in Russia: Multi-center oBsErvational ReGistry StudyNCT06521229 · 2024-06-27 · 2 site observations
RECRUITING
Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)NCT06472310 · 2024-06-06 · 2 site observations
RECRUITING
A Safety and Efficacy Study of Bevacizumab, Paclitaxel, Carboplatin Compared to Avastin® in Non-Small Cell Lung CancerNCT05654454 · 2023-05-31 · 6 site observations
RECRUITING
A Study Providing Treatment Access in Participants With Pulmonary Hypertension Completing a Parent Study and Having no Other OptionNCT05179876 · 2022-05-04 · 1 site observation
RECRUITING
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsNCT04373564 · 2021-03-24 · 3 site observations
RECRUITING
AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple SclerosisNCT05832515 · 2020-10-01 · 1 site observation
RECRUITING
Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)NCT04293796 · 2019-10-08 · 1 site observation
RECRUITING
The Role of Concomitant Diseases in Postoperative Complications Risk Stratification.NCT03945968 · 2019-07-01 · 2 site observations
RECRUITING
Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With SchizophreniaNCT03817502 · 2019-06-06 · 4 site observations
RECRUITING
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaNCT03460977 · 2018-04-17 · 3 site observations
RECRUITING
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsNCT03175224 · 2017-09-27 · 1 site observation
RECRUITING
Biobank and Register of Patients With Agresive Tumors for Translational and Analytical ResearchNCT05539677 · 1998-09-01 · 1 site observation
RECRUITING
Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian FederationNCT07146113 · 2025-06-30 · 1 site observation
SUSPENDED
Single-Stage Prepectoral Placement of Textured Implants Using a Polyester Mesh Endoprostheses With Fluoropolymer Coating in Patients With Breast CancerNCT07185334 · 2025-05-15 · 1 site observation
ACTIVE_NOT_RECRUITING
A Comparative Study of Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity of RPH-035 and Ocrevus® in Patients With Relapsing-remitting or Secondary Progressive Multiple Sclerosis With ExacerbationsNCT07597668 · 2025-04-16 · 3 site observations
ACTIVE_NOT_RECRUITING
A Study to Investigate Efficacy and Safety of Tozorakimab Injections Compared With Placebo in Adult Participants With Symptomatic Chronic Obstructive Pulmonary Disease (COPD) With a History of COPD Exacerbations and Elevated EosinophilsNCT06897748 · 2025-04-12 · 1 site observation
COMPLETED
Study of Patient With Frequent COPD ExacerbationsNCT07221981 · 2024-12-16 · 2 site observations
COMPLETED
Hemoperfusion Efferon LPS During Cardiac Surgery Using Cardiopulmonary BypassNCT06659289 · 2024-11-11 · 1 site observation
TERMINATED
A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate CancerNCT07553988 · 2024-10-24 · 2 site observations
ACTIVE_NOT_RECRUITING
A Prospective Non-interventional Study to Evaluate Clinical Outcomes of Ribociclib Combined With Endocrine Therapy in Elderly Patients With HR+HER2 - Advanced Breast Cancer in Routine Clinical Practice in Russian FederationNCT06625333 · 2024-10-11 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study to Investigate the Effects of Durvalumab With Oleclumab Following Chemoradiation in Participants With Locally Advanced Unresectable Non-Small Cell Lung Cancer (LADOGA)NCT06606847 · 2024-09-24 · 2 site observations
ACTIVE_NOT_RECRUITING
Real-world Study Assessing Efficacy of TezepeLumaB in Patients With Severe Asthma Regardless of Phenotype in RussiaNCT06566885 · 2024-09-10 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of the Efficacy, Safety and Pharmacokinetics of RPH-051 and Perjeta® in Combination With Trastuzumab and Docetaxel as the 1st Line Therapy in Patients With HER2-positive Breast CancerNCT07386938 · 2024-08-09 · 5 site observations
ACTIVE_NOT_RECRUITING
The OPBC-07/microNAC StudyNCT06529302 · 2024-05-15 · 1 site observation
ACTIVE_NOT_RECRUITING
PRospectIve ObseRvatIonal mulTicenter Study of Patients With Arterial hYpertension and CKD in the Population of RussiaNCT06372431 · 2024-04-27 · 1 site observation
COMPLETED
A Study to Investigate the Efficacy and Safety of Baxdrostat in Participants With Uncontrolled Hypertension on Two or More Medications Including Participants With Resistant HypertensionNCT06344104 · 2024-04-08 · 2 site observations
COMPLETED
Treatment and Biomarker Testing Patterns,Treatment Outcomes in a/m NSCLC With and Without Actionable Genomic AlterationsNCT06245837 · 2024-03-20 · 1 site observation
ACTIVE_NOT_RECRUITING
MultIceNtre Non-intERVentional Study for Efficacy,Safety Evaluation of BREZTRI in Pts With COPD in RussiANCT06422676 · 2023-12-29 · 1 site observation
COMPLETED
DMB-I in the Treatment of Alzheimer Type DementiaNCT06292351 · 2023-12-27 · 1 site observation
COMPLETED
A Study to Investigate the Effects of PT027 (Budesonide/Albuterol Sulfate) Metered-dose Inhaler Compared With Placebo on Exercise-Induced Bronchoconstriction in Adult Patients With AsthmaNCT06245551 · 2023-12-22 · 1 site observation
COMPLETED
Efficacy and Safety Clinical Study of RPH-104 in Adult Onset Still's Disease (AOSD)NCT05432960 · 2023-12-01 · 2 site observations
WITHDRAWN
Ulcers Formation After Hand-Sewn vs Stapled Gastrojejunal Anastomosis In MGB.NCT06077955 · 2023-11-01 · 1 site observation
UNKNOWN
Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS MutationsNCT06229340 · 2023-10-03 · 1 site observation
UNKNOWN
Survival Monitoring in Russian Cancer RegistriesNCT06043947 · 2023-08-01 · 1 site observation
ACTIVE_NOT_RECRUITING
A Non-interventional Prospective Study of Early HER2-negative High-risk Breast Cancer and BRCA1/2 Mutations Prevalence in RussiANCT05939128 · 2023-06-30 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based ChemotherapyNCT05941897 · 2023-06-21 · 2 site observations
ACTIVE_NOT_RECRUITING
Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid ArthritisNCT06175338 · 2023-06-14 · 3 site observations
UNKNOWN
HER2(Human Epidermal Growth Factor Receptor 2) -Positive Metastatic Breast Cancer in RussiaNCT05905939 · 2023-05-31 · 1 site observation
COMPLETED
HER2-low Unresectable and/or Metastatic Breast Cancer in RussiaNCT05913440 · 2023-05-30 · 1 site observation
COMPLETED
Evaluation of Insulin Glulisine (GP40321) Compared to Insulin Glulisine (Apidra® SoloStar®) in Type 1 Diabetes Mellitus PatientsNCT07070752 · 2023-04-14 · 10 site observations
COMPLETED
How to interpret this record
CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.